What is the rationale for using genome-wide NGS in the setting of precision cancer medicine?

What is the rationale for using genome-wide NGS in the setting of precision cancer medicine?

What is the rationale for using genome-wide NGS in the setting of precision cancer medicine?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professor Lynn Wang, MD, PhD, FCAP

Professor Lynn Wang, MD, PhD, FCAP

Professor, Division of Genomic and Molecular Pathology
Founding Medical Director
Genomic and Molecular Pathology
University of Chicago Medical Center
Chicago, IL, USA